Moreover, when stimulated peripheral blood mononuclear cells from RA patients are treated with recombinant IL-25, Th17 cells and IL-17A expression are inhibited and that of IL-4 increased (78). This evidence concerns the gene IL25 and rheumatoid arthritis.